Crossmark

The river blindness drug <scp>I</scp> vermectin and related macrocyclic lactones inhibit <scp>WNT</scp> ‐ <scp>TCF</scp> pathway responses in human cancer

Crossref DOI link: https://doi.org/10.15252/emmm.201404084

Published Online: 2014-08-20

Published Print: 2014-10

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Melotti, Alice

Mas, Christophe

Kuciak, Monika

Lorente‐Trigos, Aiala

Borges, Isabel

Ruiz i Altaba, Ariel
License Information

Version of Record valid from 2014-08-20
More Information

Publication History

Received: 2014-03-18

Accepted: 2014-07-15

Published: 2014-08-20